Transformation of a series of saturated isomeric steroidal diols by Aspergillus tamarii KITA reveals a precise stereochemical requirement for entrance into the lactonization pathway

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 5, 2010, Pages 352-358

  Hunter, A Christy ^a   Collins, Catherine ^a   Dodd, Howard T ^a   Dedi, Cinzia ^a   Koussoroplis, Salomé Juliette ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

17 Hydroxysteroid dehydrogenase; Aspergillus tamarii; Baeyer Villiger oxidase; Fungus; Hydroxylation; Lactonization; Steroidal diol

Indexed keywords

3BETA ANDROSTANEDIOL; ALCOHOL; ANDROSTERONE; HYDROXYL GROUP; HYDROXYSTEROID DEHYDROGENASE; LACTONE; OXYGENASE; PROGESTERONE; STEROID; TESTOLACTONE;

ARTICLE; ASPERGILLUS; ASPERGILLUS TAMARII; BAEYER VILLIGER REACTION; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; ENZYME ACTIVITY; INFRARED RADIATION; LACTONIZATION; LIPID OXIDATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STEROID BINDING; STEROID HYDROXYLATION;

ANDROSTANE-3,17-DIOL; ASPERGILLUS; HYDROXYLATION; ISOMERISM; MOLECULAR STRUCTURE; OXIDATION-REDUCTION;

ASPERGILLUS TAMARII; FUNGI;

EID: 77958474237     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.08.010     Document Type: Article

References (37)

1. Brannon D.R., Martin J., Oehlschlager A.C., Durham N.N., Zalkow L.H. Transformation of progesterone and related steroids by Aspergillus tamarii. J. Org. Chem. 1965, 30:760-762.
2. Hunter A.C., Carragher N.E. Flexibility of the endogenous progesterone lactonisation pathway in Aspergillus tamarii KITA: transformation of a series of cortical steroid analogues. J. Steroid Biochem. Mol. Biol. 2003, 87:301-308.
3. Hunter A.C., Elsom J., Ross L., Barrett R. Ring-B functionalized androst-4-en-3-ones and ring-C substituted pregn-4-en-3-ones undergo differential transformation in Aspergillus tamarii KITA: ring-A transformation with all C-6 substituted steroids and ring-D transformation with C-11 substituents. Biochim. Biophys. Acta 2006, 1761:360-366.
4. Hunter A.C., Kennedy S., Clabby S.-J., Elsom J. Fate of novel Quasi reverse steroidal substrates by Aspergillus tamarii KITA: bypass of lactonisation and an exclusive role for the minor hydroxylation pathway. Biochim. Biophys. Acta 2005, 1734:190-197.
5. 4 isomerase pathway. Biochim. Biophys. Acta 2009, 1791:110-117.
6. Hunter A.C., Khuenl-Brady H., Barrett P., Dodd H.T., Dedi C. Transformation of some 3α-substituted steroids by Aspergillus tamarii KITA reveals stereochemical restriction of steroid binding orientation in the minor hydroxylation pathway. J. Steroid Biochem. Mol. Biol. 2010, 118:171-176.
7. Hunter A.C., Bergin-Simpson H. Distinct metabolic handling of 3β-hydroxy-17a-oxa-D-homo-5α-androstan-17-one by the filamentous fungus Aspergillus tamarii KITA: evidence in support of the steroid/hydroxylase binding hypothesis. Biochim. Biophys. Acta 2007, 1771:1254-1261.
8. Kraut D.A., Sigala P.A., Fenn T.D., Herschlag D. Dissecting the paradoxical effects of hydrogen bond mutations in the ketosteroid isomerase oxyanion hole. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1960-1965.
9. Chakravorty D.K., Soudackov A.V., Hammes-Schiffer S. Hybrid quantum/classical molecular dynamics simulations of the proton transfer reactions catalysed by ketosteroid isomerase: analysis of hydrogen bonding, conformational motions and electrostatics. Biochemistry 2009, 48:10608-10619.
10. Dhagat U., Endo S., Sumii R., Hara A., El-Kabbani O. Selectivity determinants of inhibitor binding to human 20 alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme internary complex with coenzyme and potent inhibitor 3,5-dichlorosalicylic acid. J. Med. Chem. 2008, 51:4844-4848.
11. Mast N., Graham S.E., Andersson U., Bjorkhem I., Hill C., Peterson J., Pikuleva I.A. Cholesterol binding to cytochrome P450 7A1, a key enzyme in bile acid biosynthesis. Biochemistry 2005, 44:3259-3271.
12. Shi R, Lin S.X. Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation. J. Biol. Chem. 2004, 279:16778-16785.
13. Mazumder D., Khan K., Bruice T.C. Computational study of ketosteroid isomerase: insights from molecular dynamics simulation of enzyme bound substrate and intermediate. J. Am. Chem. Soc. 2003, 125:7553-7561.
14. 5-steroid isomerase: recruitment of aspartate-99 as the base. Biochemistry 2000, 39:3351-3359.
15. 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate. Biochemistry 1998, 37:14701-14712.
16. Numazawa M., Tachibana M., Tateda Y. 4-Oxygenated androst-5-en-17-ones and their 7-oxo derivatives as aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 1996, 58:431-438.
17. Hanson J.R., Hitchcock P.B., Hunter A.C. The microbiological hydroxylation of 3,16-disubstituted androstanes by Cephalosporium aphidicola. Phytochemistry 1998, 49:1287-1293.
18. Oliveira A.G., Coelho P.H., Guedes F.D., Mahecha G.A.B., Hess R.A., Oliveira C.A. 5α-Andrsotane-3β,17β-diol (3β-diol) an estrogenic metabolite of 5α-dihydrotestosterone, is a potent modulator of estrogen receptor ER beta expression in the ventral prostate of adult rats. Steroids 2007, 72:914-922.
19. Pettersson H., Holmberg L., Axelson M., Norlin M. CYP7B1-mediated metabolism of dehydroepiansdrosterone and 5α-androstane-3β,17β-diol-potential role(s) for estrogen signalling. FEBS J. 2008, 275:1778-1789.
20. Sugiyama N., Andersson S., Lathe R., Fan X., Alonso-Magdalena P., Schwend T., Nalvarte I., Warner M., Gustafsson J.A. Spatiotemporal dynamics of the expression of estrogen receptors in the postnatal mouse brain. Mol. Psychiatry 2009, 14:223-232.
21. Sikora M.J., Cordero K.E., Larious J.M., Johnson M.D., Lippman M.E., Rae J.M. The androgen metabolite 5α-androstane-3β,17β-diol induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Res. Treat. 2009, 115:289-296.
22. Omoto Y., Lathe R., Warner M., Gustafsson J.A. Early onset of puberty and early ovarian failure in CYP7B1 knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2814-2819.
23. Aspinall S.R., Stamp S., Davison A., Shenton B.K., Lennard T.W.J. The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines. J. Steroid Biochem. Mol. Biol. 2004, 88:37-51.
24. Nunlist E.H., Dozmorov I., Tang Y., Cowan R., Centola M., Lin H.-K. Partitioning of 5α-androstane-3α,17β-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation. J. Steroid Biochem. Mol. Biol. 2004, 91:157-170.
25. Pattersson H., Lundqvist J., Oliw E., Norlin M. CYP7B1-mediated metabolism of 5α-androstane-3α,17β-diol (3α-Adiol): a novel pathway for potential regulation of the cellular levels of androgens and neurosteroids. Biochim. Biophys. Acta. Mol. Cell Biol. Lipid 2009, 1791:1206-1215.
26. Higashi T., Nagura Y., Shimada K., Toyo'oka T. Studies on neurosteroids XXV1. Fluoxetine-evoked changes in rat brain and serum levels of neuroactive androgen, 5α-androstane-3α,17β-diol. Biol. Pharm. Bull. 2009, 32:1636-1638.
27. Frye C.A., Ryan A., Rhodes M. Antiseizure effects of 3α-androstanediol and/or 17β-estradiol may involve actions at the estrogen receptor β. Epilepsy Behav. 2009, 16:418-422.
28. 1H NMR spectra of steroid hormones, their hydroxylated derivatives and related compounds. J. Chem. Soc. Perkin Trans. 1990, 2:1567-1594.
29. 13C NMR of steroids-a survey and commentary. Org. Magn. Reson. 1977, 9:439-463.
30. Benach J., Filling C., Oppermann U.C.T., Roversi P., Bricogne G., Berndt K.D., Jörnvall H., Ladenstein R. Stucture of bacterial 3β/17β-hydroxysteroid dehydrogenase at 1.2Å resolution: a model for multiple steroid recognition. Biochemistry 2002, 41:14659-14668.
31. Heri V., Frankenstein J., Meitinger N., Muller-Uri F., Kreis W. A(5)-3β-hydroxysteroid dehydrogenase (3β-HSD) from Digitalis lanata. Heterologous expression and characterisation of the recombinant enzyme. Planta Med. 2007, 73:704-710.
32. Gangloff A., Shi R., Nahoum V., Lin S.-X. Pseudo-symmetry of C-19-steroids, alternative binding orientations and multispecificity in human estrogenic 17β-hydroxysteroid dehydrogenase. FASEB J. 2002, 16. 10.1096/fj.02-0026fje.
33. Qui W., Zhou M., Labrie F., Lin S-X. Crystal structures of the multispecific 17β-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues. Mol. Endocrinol. 2004, 18:1798-1807.
34. Farrants A-K.Ö., Björkhem I., Pedersen J.I. Identification of 3α,7α,12α-trihydroxy-5β-cholest-24-enoic acid as an intermediate in the peroxisomal conversion of 3α,7α,12α-trihydroxy-5β-cholestenoic acid to cholic acid. Biochim. Biophys. Acta. Lipids Lipid Metab. 1989, 1002:198-202.
35. Shan L.-H., Liu H.-M., Huang K.-X., Dai G.-F., Cao C., Dong R.-J. Synthesis of 3β,7α,11α-trihydroxy-pregn-21-benzylidene-5-en-20-one derivatives and their cytotoxic activities. Bioorg. Med. Chem. Lett. 2009, 19:6637-6639.
36. Reeder A.Y., Joannou G.E. 15β-Hydroxysteroids (Part IV). Steroids of the human perinatal period: the synthesis of 3α,15β,17α-trihydroxy-5α-pregnan-20-one and it's A/B-ring configurational isomers. Steroids 1995, 60:796-801.
37. Christakoudi S., Cowan D.A., Taylor N.F. A new marker for early diagnosis of 21-hydroxylase deficiency: 3β,16α,17α-trihydroxy-5α-pregnane-7,20-dione. J. Steroid Biochem. Mol. Biol. 2010, 121:574-581.